Pneumococcal 23-polyvalent vaccine Disease Interactions
There are 2 disease interactions with pneumococcal 23-polyvalent vaccine.
Pneumococcal 23 valent vaccine (applies to pneumococcal 23-polyvalent vaccine) cardiovascular disease
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Pulmonary Heart or Vascular Disease
Caution and appropriate monitoring should be exercised when administering pneumococcal 23 valent vaccine to individuals with severely compromised cardiovascular and/or pulmonary function in whom a systemic reaction would pose a significant risk.
References (1)
- (2022) "Product Information. Pneumovax 23 (pneumococcal 23-polyvalent vaccine)." Merck & Co., Inc
Vaccines (inactivated)/toxoids (applies to pneumococcal 23-polyvalent vaccine) immunodeficiency
Moderate Potential Hazard, High plausibility.
The expected serum antibody responses may not be obtained when vaccines and/or toxoids are administered to patients with primary or acquired immunodeficiency, including those with severe combined immunodeficiency, hypogammaglobulinemia or agammaglobulinemia, HIV infection, altered immune states (due to diseases such as leukemia, lymphoma, or generalized malignancy), or immunosuppression due to drug or other treatments (e.g., corticosteroids, alkylating agents, antimetabolites, or radiation).
References (15)
- (2001) "Product Information. Tetanus Toxoid Adsorbed (tetanus vaccine)." Aventis Pharmaceuticals
- (2022) "Product Information. Typhim VI (typhoid vaccine, inactivated)." Apothecon Inc
- (2022) "Product Information. Pneumovax 23 (pneumococcal 23-polyvalent vaccine)." Merck & Co., Inc
- "Product Information. Fluzone (influenza virus vaccine, inactivated)." Connaught Laboratories Inc
- "Product Information. Omnihib (haemophilus b conjugate vaccine (obsolete))." SmithKline Beecham
- "Product Information. Menomune A/C/Y/W-135 (meningococcal polysaccharide vaccine)." Connaught Laboratories Inc
- (2001) "Product Information. Plague Vaccine (plague vaccine)." Greer Laboratories Inc
- American Academy of Pediatrics. Committee on Infectious Diseases; Peter G, ed. (1997) "Red BooK: Report of the Committee on Infectious Diseases." Grove Village, IL: American Academy of Pediatrics
- "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham
- (2022) "Product Information. Engerix-B (HepB) (hepatitis B adult vaccine)." Apothecon Inc
- (2006) "Product Information. Gardasil (human papillomavirus vaccine)." Merck & Co., Inc
- (2009) "Product Information. Cervarix (human papillomavirus vaccine)." GlaxoSmithKline
- (2022) "Product Information. Prevnar 13 (pneumococcal 13-valent conjugate vaccine)." Apothecon Inc
- (2016) "Product Information. Gardasil 9 (human papillomavirus vaccine)." Merck & Co., Inc
- (2025) "Product Information. Vimkunya Prefilled Syringe (cvx 329) (chikungunya vaccine, recombinant (cvx 329))." Bavarian Nordic, Inc.
Switch to consumer interaction data
Pneumococcal 23-polyvalent vaccine drug interactions
There are 304 drug interactions with pneumococcal 23-polyvalent vaccine.
More about pneumococcal 23-polyvalent vaccine
- pneumococcal 23-polyvalent vaccine consumer information
- Check interactions
- Compare alternatives
- Reviews (19)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bacterial vaccines
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.